Condition

Acute Myeloid Leukemia

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 16 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials16
Recruiting1
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

16 shown
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18
RECRUITING
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9NCT05212103 · 2023-09-01
ENROLLING_BY_INVITATION
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic CancersNCT04083170 · 2022-10-06
TERMINATED
A Study to Investigate 14C-bemcentinib in Healthy Male SubjectsNCT06469138 · 2022-08-02
COMPLETED
The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETED
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.NCT04671693 · 2020-12-24
ACTIVE_NOT_RECRUITING
National Cancer Institute "Cancer Moonshot Biobank"NCT04314401 · 2020-11-11
ACTIVE_NOT_RECRUITING
SARS-CoV-2 Donor-Recipient Immunity TransferNCT04666025 · 2020-09-23
COMPLETED
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13
COMPLETED
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerNCT03154190 · 2017-08-08
COMPLETED
Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsNCT02856178 · 2017-04-20
WITHDRAWN
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic MalignanciesNCT02743351 · 2016-12-20
COMPLETED
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesNCT02498665 · 2015-11-01
COMPLETED
CINC424A2X01B Rollover ProtocolNCT02386800 · 2015-03-05
ACTIVE_NOT_RECRUITING
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesNCT02223052 · 2014-10-27
COMPLETED
Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary AspergillosisNCT00391014 · 2006-01-01
COMPLETED

Common interventions

Trial status mix

COMPLETED9
ACTIVE_NOT_RECRUITING3
ENROLLING_BY_INVITATION1
RECRUITING1
TERMINATED1
WITHDRAWN1

Phase mix

PHASE15
PHASE25
NA2
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.